10 Big Pharma smartphone apps; 5 Drug Delivery Companies to Watch;

Biotech IT News

> 10 Big Pharma smartphone apps. Slideshow

> 15 mobile apps in Life Sciences - 2012. Slideshow

> Fierce's Top 10 Biotech Techies. Special Report

> FDA dishes out long-awaited guidance on social media. Article

> Roche getting entire workforce to use Google Apps. Story

CRO News

> 'Dateline' exposé snares Indian CROs in an ethics 'sting'. More

> Report: 438 died in Indian clinical trials last year. Article

> Top Emerging CRO Markets. Special Report

> FierceCRO's Top 5 Strategic CRO/Pharma Partnerships. Special Report

> Top CRO executives predict industry's future. Story

Pharma Manufacturing News

> FDA report shows deep problems at closed Novartis Consumer Health plant. Story

> FDA ravages Sanofi vaccine sterility process in warning letter. More

> Fierce's 2012 Top 10 FDA Red Flags. Special Report

> Novartis says Nebraska plant to reopen midyear. Article

> Explosion, fire at Teva's Pliva plant turns deadly. More

Biotech Research News

> Fish oil wipes out leukemia in mice. More

> New compound nearly wipes out HIV in cells. Story

> Top 20 Research Institute Salaries. Special Report

> Meet cancer's latest enemy: grape seed extract. Article

> Fight colon cancer with veggies, plus 2 other discoveries. More

Drug Delivery News

> Fierce's 5 Drug Delivery Companies to Watch. Special Report

> Top 5 Insulin-Delivery Techs To Watch. Special Report

> Ex-Sanofi exec takes helm at Bob Langer startup. Article

> This could be the year of nanotech-enabled medicines. Editor's Corner

> Kala Pharmaceuticals, co-launched by MIT's Langer, snags $6.2M. More

Biomarkers News

> Inflammatory protein marks heart disease. Story

> Biomarkers rescue Amgen's MAb, support Roche's Avastin. More

> Qiagen signs diagnostic biomarker deals. Article

> Biomarker could quickly diagnose heart attack. Story

> Alzheimer's marker is seen in middle age. Item

Vaccines News

> Genocea's HSV-2 vax to hit the clinic. More

> 10 promising therapeutic vaccines 2012. Special Report

> 20 Top-selling Vaccines -- H1 2012. Special Report

> Breast cancer vaccine set for large-scale testing. Article

> MedImmune to cut 200 jobs, layoffs hit vax R&D. Story

Suggested Articles

Genentech followed a $1 billion pact with Sosei Heptares with discovery deals around cancer and neurological diseases with Skyhawk and Convelo.

The partners will use wearable devices to assess how heart failure patients function and feel after being discharged from hospitals.

After spinning out two companies at the start of the year, Sosei Heptares has now inked a new deal with Roche biologics unit Genentech.